K Ribi Selected Research

Trastuzumab (Herceptin)

1/2017

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Ribi Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2007
4	Neoplasms (Cancer) 01/2022 - 02/2016
3	Disease Progression 12/2023 - 04/2008
1	Hypertension (High Blood Pressure) 12/2023
1	Sarcoma (Soft Tissue Sarcoma) 12/2023
1	Anemia 12/2023
1	Neutropenia 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Fatigue 05/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2008
1	Neoplasm Metastasis (Metastasis) 01/2007

Drug/Important Bio-Agent (IBA)

2	130-nm albumin-bound paclitaxelIBA 12/2023 - 01/2018
2	Gemcitabine FDA Link 12/2023 - 04/2008
2	Letrozole (Femara)FDA LinkGeneric 10/2021 - 05/2012
1	Alanine Transaminase (SGPT)IBA 12/2023
1	Hormones (Hormone)IBA 10/2021
1	Estrogens (Estrogen)FDA Link 10/2021
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Everolimus FDA Link 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Tamoxifen FDA LinkGeneric 05/2012
1	Gefitinib (Iressa)FDA Link 04/2008
1	Cisplatin (Platino)FDA LinkGeneric 04/2008
1	Capecitabine (Xeloda)FDA Link 01/2007
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2007

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 01/2007
4	Therapeutics 01/2017 - 12/2007
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 05/2012